SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-20-000169
Filing Date
2020-06-02
Accepted
2020-06-02 16:21:23
Documents
3
Period of Report
2020-06-02
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-kuwofferinglaunch.htm 8-K 48440
2 EXHIBIT 99.1 exhibit991companyoverview.htm EX-99.1 22834
3 EXHIBIT 99.2 exhibit992riskfactors.htm EX-99.2 399928
  Complete submission text file 0001618835-20-000169.txt   472473
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 20937213
SIC: 2834 Pharmaceutical Preparations